CiteFacts · FDA Drug Shortages · FDA source
Albuterol Sulfate Solution
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Nephron Pharmaceuticals Corporation | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) | Available | 08/04/2026 |
| Rising Pharma Holdings, Inc. | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03) | Available | 06/03/2026 |
| Ritedose Pharmaceuticals, LLC | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01) | Available | 08/04/2026 |
Source facts
Grouped generic ingredient: Albuterol Sulfate Solution · 3 package records · Latest FDA row update: 08/04/2026
Therapeutic categories: Pediatric, Pulmonary/Allergy
Dosage forms: Solution
Routes: RESPIRATORY (INHALATION)
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.